Veritable’s Seagen Inc. Common Stock SGEN Stock Holding History

Veritable’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,024	Closed	-$200K	–	813
2020 Q3	$200K	Buy	+1,024	New	+$171K	﹤0.01%	698

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Veritable's SGEN Position: Q4 2020 in Review

Veritable sold out of Seagen Inc. Common Stock (SGEN) in Q4 2020, closing a stake of 1,024 shares — an estimated $200K sold.

Veritable first reported a position in SGEN in Q3 2020 and held it in 1 quarter. The position peaked at $200K in Q3 2020. 511 funds tracked by Wall St. Rank hold SGEN as of Q4 2020.

Veritable reported no remaining Seagen Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Veritable sold 1,024 Seagen Inc. Common Stock shares in Q4 2020, an estimated $200K.
Veritable first reported a position in Seagen Inc. Common Stock in Q3 2020 and held it in 1 quarter.
Veritable's Seagen Inc. Common Stock position peaked at $200K in Q3 2020.
511 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2020.

Based on Veritable's 13F filing for Q4 2020, filed 11 Feb 2021.